The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug ...

An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...

The U.S. Food and Drug Administration's panel of independent advisers on Friday voted against the efficacy of Otsuka Pharma's ...

This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...

The controversial drugs are not yet approved by federal regulators, but advocates hope a NC law would allow the state to be ...

FDA advisers voted 10-1 against the overall benefits of using MDMA to treat PTSD, citing flawed study data, questionable research conduct. Advocates and scientists say those who received doses of ...

FDA advisers reject MDMA therapy for PTSD, amid concerns over research By Will Stone. ... The drug has been studied as a treatment for PTSD and FDA is now considering whether to approve it.

MDMA. FDA Declines To Approve MDMA-Assisted Psychotherapy as a PTSD Treatment The FDA, which approved the protocols for the studies it now questions, is asking for an additional Phase 3 clinical ...

The U.S. Food and Drug Administration's reviewers have raised efficacy concerns over Otsuka Pharma's combination drug for ...

A panel of advisers to the FDA voted against the potential use of MDMA for treating PTSD.

A panel of advisers to the FDA voted against the potential use of MDMA for treating PTSD. Search Query Show Search. Live TV. Home. Election. 2024 Election; ...

FDA advisers reject MDMA therapy for PTSD, amid concerns over research. By Will Stone. Published June 4, 2024 at 3: ... potentially jeopardizing FDA approval of the treatment. Advertisement.